ReviewJournal of cardiovascular development and disease2026
A Structured Narrative Review of Contemporary Dietary Strategies Following Acute Coronary Syndromes.
Review in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimAcute coronary syndromes (ACS) remain a leading cause of morbidity and mortality worldwide. Although a Mediterranean-style diet is recommended for secondary prevention following ACS, patients are increasingly interested in alternative dietary approaches. This structured narrative review critically compares the evidence supporting eight dietary patterns for secondary prevention following ACS.
methodsA structured literature search of PubMed/MEDLINE was performed from database inception through October 2025. Randomized controlled trials evaluating Mediterranean, Dietary Approaches to Stop Hypertension (DASH), plant-based, intermittent fasting, low-carbohydrate/ketogenic, Palaeolithic, Atkins, and Carnivore diets in adults following ACS were prioritised. Where randomized evidence in post-ACS populations was unavailable, evidence from broader cardiovascular populations was included to provide clinical context. Primary outcomes were major adverse cardiovascular events and cardiovascular mortality, while secondary outcomes included low-density lipoprotein cholesterol (LDL-c), blood pressure, body weight, and adherence to dietary interventions.
resultsTwenty-eight studies met the inclusion criteria, comprising five Mediterranean-style diet studies, seven DASH studies, four vegetarian/vegan diet studies, four intermittent fasting studies, four low-carbohydrate studies, two Atkins studies, one Palaeolithic diet study, and one Carnivore diet study. Despite the emergence and popularity of other diets, the Mediterranean diet demonstrated the strongest and most consistent evidence for reducing recurrent cardiovascular events and improving cardiovascular risk factors following ACS. DASH and plant-based dietary patterns improved cardiovascular risk factors but lacked robust post-ACS outcome data. Evidence supporting intermittent fasting, low-carbohydrate/ketogenic, Palaeolithic, Atkins, and Carnivore diets was limited, with few randomized studies and insufficient evidence to support their routine use in secondary prevention.
conclusionsA Mediterranean-style diet remains the dietary pattern supported by the strongest evidence for secondary prevention following ACS. Until further pragmatic randomized trials are available, clinicians should continue recommending Mediterranean-style dietary patterns while individualising dietary advice according to patient preferences, cultural practices, and long-term adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.